Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-16 4:08 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-16 | Grant | 4,396 | $1.99 | $8,748.04 | 51% 8.57K to 12.97K | 278% |
| 03-Dec-15 4:22 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-15 | Grant | 824 | $10.61 | $8,742.64 | 11% 7.75K to 8.57K | (29%) |
| 02-Sep-15 2:27 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-15 | Grant | 751 | $11.64 | $8,741.64 | 11% 7.0K to 7.75K | (35%) |
| 30-Jan-13 4:14 PM View: | LipoScience, Inc. (LPDX) | 30-Jan-13 | Conversion | 1,114 | -- | -- | 13% 8.73K to 9.84K | |
| 15-Mar-12 12:21 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Mar-12 | Market Purchase | 2,000 | $5.22 | $10,430.00 | 40% 5.0K to 7.0K | 44% |
| 04-Oct-11 5:09 PM View: | Biodel Inc. (ALBO) | 30-Sep-11 | Option Exercise | 3,937 | -- | -- | 26% 15.16K to 19.1K | |
| 07-Sep-11 4:51 PM View: | ICAgen Inc. (ICGN) | 02-Sep-11 | Disposition (change in control) | 25,657 | $6.00 | $153,942.00 | (100%) 25.66K to 0 | < 1% |
| 06-Sep-11 5:53 PM View: | ICAgen Inc. (ICGN) | 01-Sep-11 | Option Exercise | 11,500 | $3.32 | $38,140.00 | 81% 14.16K to 25.66K | |
| 11-Aug-11 10:50 AM View: | Biodel Inc. (ALBO) | 10-Aug-11 | Market Purchase | 10,000 | $1.16 | $11,600.00 | 194% 5.16K to 15.16K | (87%) |
| 13-May-10 4:02 PM View: | Biodel Inc. (ALBO) | 11-May-10 | Market Purchase | 5,000 | $5.59 | $27,950.00 | 3145% 0.16K to 5.16K | (97%) |
| 09-Feb-10 4:06 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 08-Feb-10 | Market Purchase | 5,000 | $6.66 | $33,300.00 | 100% 0 to 5.0K | 12% |
| 05-Jan-10 12:35 PM View: | ICAgen Inc. (ICGN) | 01-Jan-10 | Grant | 29,724 | -- | -- | 36% 83.54K to 113.26K | |
| 18-Dec-09 1:32 PM View: | ICAgen Inc. (ICGN) | 17-Dec-09 | Option Exercise | 2,396 | $0.50 | $1,198.00 | 3% 81.14K to 83.54K | (54%) |
| 19-May-09 2:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-May-09 | Option Exercise | 3,333 | $10.05 | $33,496.70 | 13% 26.38K to 29.72K | |
| 19-May-09 2:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-May-09 | Market Option Sale (Planned) | 3,333 | $28.44 | $94,790.50 | (11%) 29.72K to 26.38K | (518%) |
| 12-May-09 2:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-09 | Option Exercise | 3,333 | $10.05 | $33,496.70 | 13% 26.38K to 29.72K | |
| 12-May-09 2:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-09 | Market Option Sale (Planned) | 3,333 | $30.41 | $101,357.00 | (11%) 29.72K to 26.38K | (478%) |
| 05-May-09 12:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-09 | Option Exercise | 3,334 | $10.05 | $33,506.70 | 13% 26.38K to 29.72K | |
| 05-May-09 12:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-09 | Market Option Sale (Planned) | 3,334 | $30.08 | $100,287.00 | (11%) 29.72K to 26.38K | (484%) |
| 31-Mar-09 2:55 PM View: | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 2,000 | $95.00 | $190,000.00 | (100%) 2.0K to 0 | < 1% |
| 09-Mar-09 3:58 PM View: | ICAgen Inc. (ICGN) | 05-Mar-09 | Grant | 29,787 | -- | -- | 58% 51.35K to 81.14K | |
| 28-May-08 1:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-May-08 | Option Exercise | 3,333 | $14.20 | $47,328.60 | 13% 26.38K to 29.72K | 92% |
| 28-May-08 1:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-May-08 | Market Option Sale (Planned) | 3,333 | $26.74 | $89,127.60 | (11%) 29.72K to 26.38K | (557%) |
| 21-May-08 3:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-May-08 | Option Exercise | 3,333 | $14.20 | $47,328.60 | 13% 26.38K to 29.72K | 94% |
| 21-May-08 3:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-May-08 | Market Option Sale (Planned) | 3,333 | $27.60 | $92,000.70 | (11%) 29.72K to 26.38K | (537%) |
| 15-May-08 3:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-May-08 | Option Exercise | 3,334 | $14.20 | $47,342.80 | 13% 26.38K to 29.72K | 90% |
| 15-May-08 3:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-May-08 | Market Option Sale (Planned) | 3,334 | $27.19 | $90,657.80 | (11%) 29.72K to 26.38K | (546%) |
| 08-Feb-08 4:12 PM View: | Genentech Inc. (DNA) | 06-Feb-08 | Option Exercise | 15,000 | $18.60 | $279,000.00 | 750% 2.0K to 17.0K | |
| 08-Feb-08 4:12 PM View: | Genentech Inc. (DNA) | 06-Feb-08 | Market Option Sale | 15,000 | $71.01 | $1,065,150.00 | (88%) 17.0K to 2.0K | (32%) |
| 08-May-07 2:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-07 | Option Exercise | 10,000 | $19.78 | $197,800.00 | 38% 26.38K to 36.38K | |
| 08-May-07 2:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-07 | Market Option Sale | 10,000 | $30.53 | $305,300.00 | (27%) 36.38K to 26.38K | (476%) |
| 26-Jan-07 10:55 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Jan-07 | Grant | 383 | $0.01 | $3.83 | 1% 26.0K to 26.38K | |
| 11-Dec-06 11:46 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Dec-06 | Option Exercise | 2,000 | $13.23 | $26,460.00 | 4% 55.0K to 57.0K | |
| 11-Dec-06 11:46 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Dec-06 | Market Option Sale (Planned) | 2,000 | $42.95 | $85,900.00 | (4%) 57.0K to 55.0K | (309%) |
| 11-Dec-06 11:46 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Dec-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 11-Dec-06 11:46 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Dec-06 | Market Option Sale (Planned) | 3,000 | $43.97 | $131,910.00 | (5%) 58.0K to 55.0K | (300%) |
| 07-Dec-06 12:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Dec-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 07-Dec-06 12:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Dec-06 | Market Option Sale (Planned) | 3,000 | $44.71 | $134,130.00 | (5%) 58.0K to 55.0K | (293%) |
| 06-Dec-06 1:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Dec-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 06-Dec-06 1:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Dec-06 | Market Option Sale (Planned) | 3,000 | $44.51 | $133,530.00 | (5%) 58.0K to 55.0K | (295%) |
| 05-Dec-06 2:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Dec-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 05-Dec-06 2:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Dec-06 | Market Option Sale (Planned) | 3,000 | $44.28 | $132,840.00 | (5%) 58.0K to 55.0K | (297%) |
| 04-Dec-06 3:46 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Dec-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 04-Dec-06 3:46 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Dec-06 | Market Option Sale (Planned) | 3,000 | $43.86 | $131,580.00 | (5%) 58.0K to 55.0K | (301%) |
| 01-Dec-06 1:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Nov-06 | Option Exercise | 3,000 | $13.23 | $39,690.00 | 5% 55.0K to 58.0K | |
| 01-Dec-06 1:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Nov-06 | Market Option Sale (Planned) | 3,000 | $44.54 | $133,620.00 | (5%) 58.0K to 55.0K | (294%) |
| 13-Nov-06 9:43 PM View: | Fisher Scientific Internati... (FSH) | 09-Nov-06 | Disposition | 2,000 | -- | -- | (100%) 2.0K to 0 | |
| 09-May-06 4:59 PM View: | Fisher Scientific Internati... (FSH) | 05-May-06 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 28-Nov-05 5:22 PM View: | ICAgen Inc. (ICGN) | 23-Nov-05 | Market Purchase | 5,000 | $6.03 | $30,150.00 | 11% 46.35K to 51.35K | (96%) |
| 31-Aug-05 10:18 AM View: | Biopure Corp. (BPUR) | 30-Aug-05 | Market Purchase | 10,000 | $1.42 | $14,244.00 | 64% 15.66K to 25.66K | (92%) |